The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2019

Filed:

Jan. 30, 2015
Applicant:

Cellnovo Limited, Swansea, GB;

Inventors:

Julian Shapley, Swansea, GB;

Matthew Powell, Swansea, GB;

Ceri Clatworthy, Swansea, GB;

Joseph Cefai, Swansea, GB;

Assignee:

INSULET NETHERLANDS B.V., Schiphol, NL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/142 (2006.01); A61M 5/20 (2006.01); A61M 5/50 (2006.01); A61M 5/315 (2006.01); A61B 5/145 (2006.01); G06F 19/00 (2018.01); A61M 5/24 (2006.01);
U.S. Cl.
CPC ...
A61M 5/14244 (2013.01); A61B 5/14532 (2013.01); A61M 5/2033 (2013.01); A61M 5/31546 (2013.01); A61M 5/50 (2013.01); A61M 5/5086 (2013.01); G06F 19/3468 (2013.01); A61M 2005/14268 (2013.01); A61M 2005/2073 (2013.01); A61M 2005/244 (2013.01); A61M 2205/121 (2013.01); A61M 2205/123 (2013.01); A61M 2205/27 (2013.01); A61M 2205/273 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2230/201 (2013.01);
Abstract

A therapeutic product delivery device is described which comprises a device body and a cartridge for holding a therapeutic product. An engagement structure is provided for releasably engaging the cartridge with the device body. A fault detector is provided for detecting a fault in the delivery of the therapeutic product from the cartridge. A release trigger is responsive to the detection of a fault to cause the engagement structure to release the cartridge from the device body. In this way, a fault causes the cartridge to be released from the device body, which will prevent any further delivery of the therapeutic product to the patient. This solution is strongly preferable to a solution in which a product delivery mechanism (e.g. a pump) is merely paused or stopped, since when the cartridge separates then no further delivery is possible at all, until the cartridge is reattached (or more probably replaced with a new cartridge in case the fault is with the cartridge).


Find Patent Forward Citations

Loading…